| Bismuth subsalicylate in the treatment of gastritis due to Campylobacter pylori. | |
| | |
MedLine Citation:
|
PMID: 2406863 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Fifty patients completed an investigator-blind trial comparing bismuth subsalicylate, erythromycin ethylsuccinate, and placebo matched to the bismuth salt in the treatment of gastritis associated with Campylobacter pylori. C. pylori was cleared from 14 (77.8%) of 18 patients given locally active bismuth, from one (6.7%) of 15 patients given erythromycin, and from none of 17 patients given placebo. Gastritis resolved in 13 (81%) of 16 patients treated with bismuth but in only three of 13 receiving erythromycin and in none of 16 patients given placebo. Results of endoscopic examination showed greater improvement in patients cleared of C. pylori than in those with persistent infection. Heartburn improved in 50% of patients who received bismuth compared with 17% of those given placebo. The success of bismuth is probably due to its local antimicrobial activity. Erythromycin may have been inactivated by the low pH in the areas colonized with C. pylori. Relapse is less frequent when a combination of bismuth and an antimicrobial agent is used; such a combination is characterized by local and systemic activity, stability at low pH, and good penetration into gastric mucus. |
| | |
Authors:
|
C A McNulty |
Related Documents
:
|
3225433 - Ammonium nitrate cold pack ingestion. 8635943 - Feasibility study of the treatment of primary unresectable carcinoma of the pancreas wi... 2904423 - Fertility studies in sickle cell disease: semen analysis in adult male patients. |
Publication Detail:
|
Type: Clinical Trial; Journal Article; Randomized Controlled Trial |
Journal Detail:
|
Title: Reviews of infectious diseases Volume: 12 Suppl 1 ISSN: 0162-0886 ISO Abbreviation: Rev. Infect. Dis. Publication Date: 1990 Jan-Feb |
Date Detail:
|
Created Date: 1990-03-23 Completed Date: 1990-03-23 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 7905878 Medline TA: Rev Infect Dis Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: S94-8 Citation Subset: IM |
Affiliation:
|
Gloucester Public Health Laboratory, United Kingdom. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Bismuth / therapeutic use* Campylobacter Infections / drug therapy* Chi-Square Distribution Erythromycin Ethylsuccinate / therapeutic use* Female Follow-Up Studies Gastric Mucosa / pathology Gastritis / drug therapy* Gastroscopy Humans Male Middle Aged Organometallic Compounds / therapeutic use* Randomized Controlled Trials as Topic Salicylates / therapeutic use* |
| Chemical | |
Reg. No./Substance:
|
0/Organometallic Compounds; 0/Salicylates; 1264-62-6/Erythromycin Ethylsuccinate; 14882-18-9/bismuth subsalicylate; 7440-69-9/Bismuth |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Campylobacter pylori: its link to gastritis and peptic ulcer disease.
Next Document: Epidemiology and pathophysiology of Campylobacter pylori infections.